semaglutide copay card Medicare patients may qualify to get select GLP-1 medications for a $50 monthly copay! For non-Medicare patients, pricing starts as low as $149 monthly. Stop by the pharmacy today to learn more! Wegovy® Cost & Coverage Information

Consult a healthcare professional if pregnant, planning pregnancy, or breastfeeding

How New Weight Loss Drugs May Benet Sleep Apnea The introduction of new weight loss medications oers a promising strategy to address both obesity and its associated conditions, including sleep apnea

A clinical trial could be definitive and influence the future of obesity-related cancer prevention, but it will be lengthy, complex and costly

Obese workers had higher rates of absenteeism and disability leaves

First approved in 2021, Wegovy is the only FDA-approved semaglutide treatment for weight loss and the medicine that changed how healthcare professionals (HCPs) treat people with obesity as the first weekly GLP-1 option for chronic weight management